Literature DB >> 8841237

Preeclampsia and liver infarction in early pregnancy associated with the antiphospholipid syndrome.

O M Alsulyman1, M A Castro, E Zuckerman, W McGehee, T M Goodwin.   

Abstract

BACKGROUND: Usually, preeclampsia is a disease of the second half of pregnancy (i.e., beyond 20 weeks' gestation). Early-onset preeclampsia has been reported in association with the antiphospholipid syndrome, however, the cases reported have been at 25-30 weeks' gestation. CASES: Three pregnant women presented with clinical and laboratory features of severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) before 20 weeks' gestation. On evaluation, they were found to have antiphospholipid antibodies (anticardiolipin and/or lupus anticoagulant). Two of the patients had abdominal computed tomography scans that showed a low-density area along the hepatic periphery, compatible with hepatic infarction. Spontaneous resolution of all clinical and laboratory manifestations of preeclampsia and HELLP syndrome was observed after fetal death and pregnancy termination.
CONCLUSION: Preeclampsia and HELLP syndrome can present before 20 weeks' gestation in association with the antiphospholipid syndrome and may be associated with hepatic infarction.

Entities:  

Mesh:

Year:  1996        PMID: 8841237     DOI: 10.1016/0029-7844(96)00098-1

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  14 in total

1.  HELLP syndrome complicated bile duct injury and subsequent left hepatic lobe atrophy.

Authors:  Ayse L Mindikoglu; Shilun D Li; Sherri L Yong; Marc A Borge; John Brems; David H Van Thiel
Journal:  Dig Dis Sci       Date:  2006-07       Impact factor: 3.199

Review 2.  Is there a microangiopathic antiphospholipid syndrome?

Authors:  Ronald A Asherson; Sylvia S Pierangeli; Ricard Cervera
Journal:  Ann Rheum Dis       Date:  2007-04       Impact factor: 19.103

3.  The HELLP syndrome, antiphospholipid antibodies, and syndromes.

Authors:  Ronald A Asherson; Claudio Galarza-Maldonado; Jose Sanin-Blair
Journal:  Clin Rheumatol       Date:  2007-10-03       Impact factor: 2.980

4.  Partial HELLP syndrome in pregnancy complicated by recurrent deep vein thromboses and palmar skin lesions in a patient with prothrombin gene 20210a mutation and antiphospholipid antibodies: an unusual case.

Authors:  Ronald A Asherson; Cathy Spargo; Jose A Gómez-Puerta
Journal:  Clin Rheumatol       Date:  2007-07-03       Impact factor: 2.980

5.  Preeclampsia before 20 weeks of gestation: a case report and review of the literature.

Authors:  Mari Tanaka; Yasushi Tsujimoto; Kimihiko Goto; Kana Kumahara; Saeko Onishi; Sachio Iwanari; Daiki Fumihara; Syo Miki; Masaki Ikeda; Kanae Sato; Hiroshi Sato; Masaya Hirose; Hiroya Takeoka
Journal:  CEN Case Rep       Date:  2014-08-09

6.  HELLP Syndrome at 17 Weeks Gestation: A Rare and Catastrophic Phenomenon.

Authors:  Erica L Berry; Sara N Iqbal
Journal:  J Clin Gynecol Obstet       Date:  2014-12

Review 7.  Antiphospholipid syndrome: a predisposing factor for early onset HELLP syndrome.

Authors:  Panagiotis Tsirigotis; George Mantzios; Vassiliki Pappa; Konstantinos Girkas; George Salamalekis; Angellos Koutras; Vassiliki Giannopoulou; Konstantina Spirou; Alexia Balanika; Sotirios Papageorgiou; Anthi Travlou; John Dervenoulas
Journal:  Rheumatol Int       Date:  2007-06-19       Impact factor: 2.631

8.  Association of HELLP syndrome with primary antiphospholipid syndrome--a case report.

Authors:  Katalin Veres; Károly Papp; Gabriella Lakos; Edit Szomják; Zoltán Szekanecz; Gyula Szegedi; Pál Soltész
Journal:  Clin Rheumatol       Date:  2007-08-08       Impact factor: 2.980

9.  ACG Clinical Guideline: Liver Disease and Pregnancy.

Authors:  Tram T Tran; Joseph Ahn; Nancy S Reau
Journal:  Am J Gastroenterol       Date:  2016-02-02       Impact factor: 10.864

10.  A stormy and rare presentation: Eclampsia at 18 weeks of gestation.

Authors:  Saniya Eltayeb; Vaidyanathan Gowri; Sarah Othman; Rahma Haddabi; Shahila Tazneem
Journal:  Obstet Med       Date:  2013-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.